Metis Global Partners LLC Acquires 987 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Metis Global Partners LLC increased its holdings in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 4.9% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 20,965 shares of the company’s stock after purchasing an additional 987 shares during the period. Metis Global Partners LLC’s holdings in Church & Dwight were worth $2,195,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Capital Performance Advisors LLP bought a new stake in shares of Church & Dwight during the 3rd quarter worth $27,000. Crewe Advisors LLC bought a new position in Church & Dwight in the first quarter valued at about $28,000. Ashton Thomas Securities LLC bought a new position in Church & Dwight in the third quarter valued at about $28,000. Rothschild Investment LLC bought a new position in Church & Dwight in the second quarter valued at about $31,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in Church & Dwight in the second quarter valued at about $33,000. 86.60% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Arthur B. Winkleblack sold 11,590 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $103.84, for a total value of $1,203,505.60. Following the transaction, the director now owns 7,129 shares in the company, valued at $740,275.36. This trade represents a 61.92 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Matthew Farrell sold 165,823 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $103.03, for a total value of $17,084,743.69. Following the completion of the transaction, the chief executive officer now owns 112,719 shares in the company, valued at $11,613,438.57. This represents a 59.53 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 490,613 shares of company stock worth $50,858,457. Corporate insiders own 2.00% of the company’s stock.

Church & Dwight Trading Up 1.3 %

NYSE CHD opened at $109.02 on Friday. The business has a 50 day simple moving average of $103.40 and a 200 day simple moving average of $104.05. Church & Dwight Co., Inc. has a one year low of $90.26 and a one year high of $110.31. The stock has a market capitalization of $26.71 billion, a P/E ratio of 48.89, a P/E/G ratio of 3.95 and a beta of 0.55. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.62 and a quick ratio of 1.09.

Church & Dwight (NYSE:CHD) last released its earnings results on Friday, November 1st. The company reported $0.79 EPS for the quarter, topping the consensus estimate of $0.68 by $0.11. The business had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Church & Dwight had a return on equity of 19.90% and a net margin of 9.08%. The firm’s revenue was up 3.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.74 earnings per share. Research analysts expect that Church & Dwight Co., Inc. will post 3.45 earnings per share for the current year.

Church & Dwight Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Friday, November 15th will be issued a $0.2838 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.14 annualized dividend and a yield of 1.04%. Church & Dwight’s payout ratio is currently 50.67%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Wells Fargo & Company increased their target price on Church & Dwight from $113.00 to $115.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Truist Financial dropped their target price on Church & Dwight from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, August 5th. Piper Sandler assumed coverage on Church & Dwight in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $120.00 target price for the company. Deutsche Bank Aktiengesellschaft increased their target price on Church & Dwight from $114.00 to $115.00 and gave the company a “buy” rating in a research report on Monday, November 4th. Finally, Evercore ISI decreased their price target on Church & Dwight from $110.00 to $101.00 and set an “in-line” rating for the company in a research note on Monday, August 5th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $108.53.

Church & Dwight Company Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.